Drug Combination Details
General Information of the Combination (ID: C71184) | |||||
---|---|---|---|---|---|
Name | Schisandrol A NP Info | + | Doxorubicin Drug Info | ||
Structure | + | ||||
Disease |
Hepatocellular carcinoma
[ICD-11: 2C12]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Reversing Drug Resistance by This Combination | ||||||
Reversing Drug Resistance | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
In-vitro Model | Hep-G2 | CVCL_0027 | Hepatocellular carcinoma | Homo sapiens | ||
Experimental
Result(s) |
SCH acts by affecting the normal formation and functioning of the Pgp-substrate complexes. |
References | ||||
---|---|---|---|---|
Reference 1 | Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes. Planta Med. 2007 Mar;73(3):212-20. |